CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Bupropion SRdrug
Likely dose
Bupropion SR 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01270555
NCT01270555N/ACompleted
CompareCT.gov

Efficacy Of Bupropion SR For Attention Deficit Hyperactivity Disorder (ADHD) In Adults With Recent Past or Current Substance Use Disorders

Massachusetts General Hospital·interventional·Posted Jan 5, 2011·Updated Mar 8, 2013

In Brief

A clinical study evaluating Bupropion SR for Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD). Completed, enrolled 32 participants.

Detailed Summary

The investigators propose to conduct an open study to evaluate the efficacy and tolerability of Bupropion SR using clinically relevant doses in ADHD adults with a recent history of or current substance use disorders. We hypothesize that Bupropion SR will be effective in treating ADHD in this population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAttention Deficit Hyperactivity Disorder (ADHD), Substance Use Disorder (SUD)
Countries--
Collaborators--

Timeline

N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 5, 2011
Enrollment StartMay 1, 1999
Primary CompletionJul 1, 2001
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 15.5 years ago

Interventions

Bupropion SRdrug

100mg capsules Initial dosing 100mgSR every morning, to be titrated to 200mgSR twice daily maximum